Felix, a Toronto, Canada-based provider of on-demand treatment for everyday health, raised CDN$18M in Series B funding.
The round was led by BDC Capital through its Women in Technology Venture Fund with participation from Canadian Business Growth Fund (CBGF), Whitecap Venture Partners, and Mantella Venture Partners.
The company intends to use the funds to expand the amount of patients it serves by launching new, more complex categories of care in addition to new therapeutic services.
Launched in 2019 and led by CEO Kyle Zien and COO Emma Stern, Felix provides an end-to-end platform offering on-demand treatment for everyday health. Through its digital platform, the company connects Canadians with a healthcare practitioner via text, audio, and video calls — whenever and wherever is convenient for the patient — and delivers treatments discreetly to their place. Patients can then check back in with their healthcare practitioner at any time.
The company on-demand treatment for erectile dysfunction, weight loss, hair loss, HIV prevention, acne, and birth control, among other categories.
Felix has over 540,000 registered users and has experienced over 200 per cent year-over-year growth.
FinSMEs
05/04/2023